Work

Pharmacological Inhibition of Rab7A Sensitizes Bortezomib-Resistant Multiple Myeloma Cells by Disrupting Lysosomal Adaptation and Stem-Like Features

Year: 2026
Type: preprint
Abstract: Objective Bortezomib resistance limits durable responses in multiple myeloma treatment. This study investigated whether pharmacological targeting of Rab7A with CID1067700 could disrupt lysosomal adaptation and resensitize bortezomib-resistant myeloma cells. Methods Dose–response profiles of bortezomib and CID1067700 were determined by MTT assay in bortezomib-sensitive RPMI 8226 and resistant RPMI 8226-7B cells. Combination effects were evaluated using Bliss independence and Highest Single Agent models. Lysosomal acidification and hydrolytic activity were assessed by flow cytometry, RAB7A protein levels by ELISA, and related gene expression by qPCR. CID1067700–RAB7A interactions were examined by molecular docking. RAB7A expression was also evaluated in bone marrow samples from patients with newly diagnosed multiple myeloma (NDMM), relapsed/refractory multiple myeloma (RRMM), and healthy controls. Results RPMI 8226-7B cells were 5.7-fold more resistant to bortezomib but showed no marked cross-resistance to CID1067700. Low-dose bortezomib increased CID1067700 sensitivity 1.2-fold in parental cells and 7.8-fold in resistant cells, with a maximum Bliss score of 47.93. Resistant cells exhibited higher basal lysosomal acidification and hydrolytic activity. CID1067700 reduced lysosomal acidification by approximately 25.3-fold at 48 h and suppressed the bortezomib-induced increase in hydrolytic activity. The combination increased the BAX/BCL2 ratio, while CID1067700 reduced BCRP/ABCG2, SOX2, OCT4, and NANOG expression in resistant cells. RAB7A expression was higher in RRMM samples. Conclusion Pharmacological Rab7 targeting disrupted lysosomal dependence and strongly resensitized bortezomib-resistant myeloma cells. Rab7A-regulated lysosomal homeostasis may represent a targetable vulnerability in bortezomib resistance.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: green
OpenAlex ID: W7235865419
Cites: 30
Cited by:
Related to: 10